Ironwood Pharma Files 2025 Proxy Statement
Ticker: IRWD · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1446847
| Field | Detail |
|---|---|
| Company | Ironwood Pharmaceuticals Inc (IRWD) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
Ironwood Pharma's proxy statement is out for the June 10th meeting - vote on directors & pay!
AI Summary
Ironwood Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting on June 10, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key details regarding director nominations, auditor ratification, and other corporate matters are presented.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership, executive pay, and strategic direction, impacting corporate governance and shareholder rights.
Risk Assessment
Risk Level: low — This is a standard DEF 14A filing, which is routine for public companies and does not inherently indicate new risks.
Key Players & Entities
- IRONWOOD PHARMACEUTICALS, INC. (company) — Registrant
- 0001104659-25-040309 (filing_id) — Accession Number
- 20250428 (date) — Filing Date
- 20250610 (date) — Conformed Period of Report (Annual Meeting Date)
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the official proxy statement for Ironwood Pharmaceuticals, Inc.'s annual meeting, detailing information for voting on corporate matters.
When is the scheduled date for Ironwood Pharmaceuticals' annual meeting?
The conformed period of report is June 10, 2025, indicating the scheduled date for the annual meeting.
Who is the filer of this proxy statement?
The filer of this proxy statement is IRONWOOD PHARMACEUTICALS, INC., as indicated by 'Filed by the Registrant'.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001446847.
What is the filing fee status for this document?
The filing indicates 'No fee required.'
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding IRONWOOD PHARMACEUTICALS INC (IRWD).